Use the Search Fields to Find Information
Page 85 of 382
Pulmonary langerhans cell histiocytosis secondary to Marijuana use: a case report and systematic review of the literature
Abstract Background Pulmonary Langerhans Cell Histiocytosis (PLCH) is a rare interstitial lung disease primarily affecting young to middle-aged smokers. While traditionally linked to tobacco use,
March 29, 2026
Pulmonary effects of inhaled cannabis smoke
Please use this link to access this publication. ABSTRACT Background: The smoke generated from cannabis delivers biologically active cannabinoids and a number of combustion-derived toxins, both
August 1, 2024
Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates
ABSTRACT Background Cannabis is one of the most widely used substances worldwide. Heavy use is associated with an increased risk of cannabis use disorders, psychotic
October 7, 2024
Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA
Please use this link to access this publication. Abstract The legality of cannabis use has been changing in a number of jurisdictions around the world. In the
May 16, 2025
PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program
Background: New Mexico was the first state to list post-traumatic stress disorder (PTSD) as a condition for the use of medical cannabis. There are no
September 19, 2019
PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program
Abstract Background: New Mexico was the first state to list post-traumatic stress disorder (PTSD) as a condition for the use of medical cannabis. There are
August 16, 2023
Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review
Please use this link to access this publication. Abstract Cannabis is the most widely used illicit drug worldwide, and it is estimated that up to
June 20, 2025
Psychosis associated with cannabis withdrawal: systematic review and case series
Abstract BackgroundAbrupt cessation of heavy cannabis use can cause a withdrawal syndrome characterised by irritability, anxiety, insomnia, reduced appetite and restlessness. Recent reports have also
November 8, 2025
Psychopathological and Cognitive Effects of Therapeutic Cannabinoids in Multiple Sclerosis: A Double-Blind, Placebo Controlled, Crossover Study
Abstract Objectives: To study possible psychopathological symptoms and cognitive deficits, abuse induction, as well as general tolerability and effects on quality of life, fatigue and motor
September 19, 2019
Psychoneuroendocrinological links between chronic stress and depression
Abstract Objective: The goal of this report is to develop a comprehensive model, which integrates psychosocial and neurobiological aspects, for better understanding the link between
August 23, 2023
Page 85 of 382